Emergency Nurses Association Announces Corporate Sponsors for 2008 Annual Conference

    DES PLAINES, Ill., Sept. 18 /PRNewswire-USNewswire/ -- The Emergency
 Nurses Association (ENA) today announced the corporate sponsors for the
 2008 ENA Annual Conference to be held in Minneapolis, MN, on September 25 -
 27, 2008.
 
     This year's sponsors are sanofi-aventis U.S. and Bristol-Myers Squibb /
 Sanofi Pharmaceuticals Partnership, Catholic Healthcare West, LifeSync
 Corporation, The Medicines Company, Otsuka America Pharmaceuticals Inc, and
 Physio-Control.
 
     "We are so pleased that these companies have chosen to support
 emergency nurses from across the country through their sponsorship of the
 2008 ENA Annual Conference," said Denise King, RN, MSN, CEN, 2008
 president, ENA. "Each of these companies has shown their commitment to
 improved patient care through their support of this meeting. By sponsoring
 the Annual Conference, each of these companies is directly contributing to
 the continued improvement of emergency care."
 
     The 2008 ENA Annual Conference will explore the conference theme,
 Pathways to Discovery, with in-depth reviews of national issues facing
 emergency care professionals, professional development sessions on career
 and management issues and an exhibit hall featuring a plethora of suppliers
 of products and services for the emergency care environment.
 
     About the 2008 Annual Conference Sponsors
 
     Catholic Healthcare West is a not-for-profit healthcare system with
 over 40 facilities in California, Nevada and Arizona. They can be found in
 the heart of the communities they serve, offering care that combines
 state-of-the-art technologies with timeless values that reflect a
 commitment to healing.
 
     LifeSync Corporation is a medical device company committed to the
 development of innovative products that improve clinical outcomes for
 patients through the use of LifeSync(R) Wireless ECG products and
 technologies.
 
     The Medicines Company is focused on advancing the treatment of critical
 care patients through the delivery of innovative, cost-effective medicines
 to the worldwide hospital marketplace. The Company markets Angiomax(R)
 (bivalirudin) in the United States and other countries for use in patients
 undergoing coronary angioplasty, a procedure to clear restricted blood flow
 in arteries around the heart. The Company also has two products in
 late-stage development, CleviprexTM (clevidipine butyrate) injectable
 emulsion and cangrelor.
 
     Otsuka America Pharmaceuticals Inc. is a successful, innovative,
 fast-growing healthcare company that commercializes Otsuka-discovered and
 other product opportunities in North America, with a strong focus on and
 commitment to neuroscience, cardiology, oncology, and gastroenterology. The
 Company is part of the Otsuka Pharmaceutical Group, which is comprised of
 104 companies and approximately 31,000 people around the world.
 
     Physio-Control pioneered defibrillation technology more than 50 years
 ago and provides LIFEPAK(R) products for cardiac emergencies in hospital
 emergency departments.
 
     For more information about the 2008 ENA Annual Conference, visit the
 ENA website at www.ena.org.
 
     About the Emergency Nurses Association
 
     The Emergency Nurses Association (ENA) is the only professional nursing
 association dedicated to defining the future of emergency nursing and
 emergency care through advocacy, expertise, innovation, and leadership.
 Founded in 1970, ENA serves as the voice of more than 35,000 members and
 their patients through research, publications, professional development,
 injury prevention, and patient education. Additional information is
 available at ENA's Web site, at www.ena.org.
 
 
 

SOURCE Emergency Nurses Association